Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell Transplantation

被引:33
作者
Abraham S. Kanate
Arnon Nagler
Bipin Savani
机构
[1] West Virginia University Cancer Institute,Hematopoietic Malignancy and Cellular Therapy
[2] Tel Aviv University,Chaim Sheba Medical Center
[3] Vanderbilt University Medical Center,Department of Hematology
关键词
Hematopoietic cell transplantation; Scientific methods; Study endpoints; Study definitions;
D O I
10.2991/chi.d.191207.001
中图分类号
学科分类号
摘要
Due to the increasingly strict word/character restrictions enforced by most scientific publications, we identified a need for a master document illustrating the “Scientific Methods” that may be applicable to the majority of observational and registry-based studies in hematopoietic cell transplantation (HCT). The purpose of this study is to serve as a reference document that describes the data source, study endpoints and statistical analyses utilized most commonly in retrospective studies in HCT. To this end we compile, define and reference the methodology commonly used in HCT research. While it is recognized that the scientific methodology may periodically require updates due to the evolving landscape of transplant research, such as newer study endpoints and statistical methods, this manuscript describes frequently used methodologies.
引用
收藏
页码:2 / 4
页数:2
相关论文
共 51 条
[1]  
Le Maistre CF(2013)Standardization of terminology for episodes of hematopoietic stem cell patient transplant care Biol Blood Marrow Transplant 19 851-7
[2]  
Farnia S(2015)Guidelines for defining and implementing standard episode of care for hematopoietic stem cell transplantation within the context of clinical trials Biol Blood Marrow Transplant 21 583-8
[3]  
Crawford S(2006)Regression models for hazard rates Biol Blood Marrow Transplant 12 107-12
[4]  
McGuirk J(2013) cumulative incidence probabilities in hematopoietic cell transplantation data Biol Blood Marrow Transplant 19 860-6
[5]  
Maziarz RT(2013)Clinical endpoints in allogeneic hematopoietic stem cell transplantation studies: the cost of freedom Bone Marrow Transplant 48 S1-S37
[6]  
Coates J(2006)On behalf of the EBMT Statistical Committee. Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation Leukemia 20 1690-700
[7]  
Majhail NS(2005)Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning Biol Blood Marrow Transplant 11 945-56
[8]  
Giralt S(1995)National Institutes of Health consensus development project on criteria for clinical trials in chronic graft- Bone Marrow Transplant 15 825-8
[9]  
Bonagura A(2003)-host disease: I. Diagnosis and staging working group report Biol Blood Marrow Transplant 9 215-33
[10]  
Crawford S(2015)1994 consensus conference on acute GVHD grading Blood 125 1333-8